Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 6/20 | 0.41 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
| ▸ | PLG | P00747 | 3/20 | 0.40 |
| ▸ | PLAT | P00750 | 2/20 | 0.40 |
| ▸ | DPP4 | P27487 | 3/20 | 0.39 |
| ▸ | FAP | Q12884 | 1/20 | 0.39 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.39 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.39 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.39 |
| ▸ | GRB2 | P62993 | 1/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | VHL | P40337 | 1/20 | 0.36 |
| ▸ | F2 | P00734 | 1/20 | 0.36 |
| ▸ | F10 | P00742 | 1/20 | 0.36 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29468837 | 0.91 | KMT2A (0.41) | DPP4FAPDPP8DPP9DPP7 | |
| SCHEMBL30972553 | 0.89 | KMT2A (0.42) | DPP4FAPDPP8DPP9DPP7 | |
| SCHEMBL29616517 | 0.86 | CAPN1 (0.51) | CAPN1CTSBPLGPLATDPP4 | |
| SCHEMBL30852860 | 0.84 | CAPN1 (0.48) | CAPN1CTSBGRB2OPRM1 | |
| SCHEMBL2194423 | 0.83 | CAPN1 (0.48) | CAPN1CTSBPLGPLATDPP4 | |
| SCHEMBL21519838 | 0.83 | CAPN1 (0.48) | CAPN1CTSBPLGPLATDPP4 | |
| SCHEMBL2184762 | 0.83 | CAPN1 (0.48) | CAPN1CTSBPLGPLATDPP4 | |
| SCHEMBL29468849 | 0.83 | REN (0.45) | GRB2F2 | |
| SCHEMBL30800860 | 0.82 | DPP4 (0.44) | CAPN1CTSBPLGPLATDPP4 | |
| SCHEMBL30800861 | 0.81 | DPP4 (0.43) | CAPN1CTSBPLGPLATDPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4598938-A2 | PEPTIDES FOR INCRETIN SYNTHESIS | Eli Lilly and Company (US) | 2025-08-13 | — | — | EP | disclosed |
| WO-2024077149-A2 | PEPTIDES FOR INCRETIN SYNTHESIS | ELI LILLY AND COMPANY (US) | 2024-04-11 | — | — | WO | disclosed |